Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/NEU stock hub

ASX/NEU has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/NEUis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.6B

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/NEU

In the news

Latest news · ASX/NEU

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E136.1

P25 12.9P50 20.4P75 41.2

Trailing P/E55

P25 14.2P50 19.2P75 35.1

ROE8.7

P25 -118.7P50 -49.4P75 -1.2

ROIC40.7

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/NEU market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

218

Groups with data

Currency

AUD

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	New Zealand
Country code	AU
Employees	8
Enterprise value	AUD 1.3B
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Biotechnology
Isin	NZNEUE0001S8
Last refreshed	2026-05-10
Market cap	AUD 1.6B
Price	AUD 12.8
Price currency	AUD
Rev Per Employee	8,081,125x
Sector	Healthcare
Sic	2836
Symbol	asx/NEU
Website	https://www.neurenpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.88%
EV Earnings	43.46x
EV/EBIT	60.01x
EV/EBITDA	59.95x
EV/FCF	10.55x
EV/Sales	20.46x
FCF yield	7.75%
Forward P/E	136.11x
P/B ratio	4.78x
P/E ratio	55.01x
P/S ratio	25.04x
PE Ratio10 Y	443.26x
PE Ratio3 Y	25.58x
PE Ratio5 Y	22.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.09%
EBITDA Margin	34.13%
FCF margin	193.95%
Gross margin	43.71%
Gross Profit	AUD 28.3M
Gross Profit Growth	-85.04%
Gross Profit Growth Q	-91.52%
Gross Profit Growth3 Y	-44.17%
Gross Profit Growth5 Y	-13.54%
Net Income	AUD 30.4M
Net Income Growth	-78.57%
Net Income Growth Q	-88.51%
Net Income Growth Years	0%
Net Income Growth3 Y	-36.22%
Net Income Growth5 Y	-11.17%
Pretax Margin	60.22%
Profit Margin	47.08%
Profit Per Employee	AUD 3.8M
Profitable Years	4
ROA	3.66
Roa5y	21.26
ROCE	6.51
ROE	8.67
Roe5y	32.35
ROIC	40.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	23.75%
Cagr15y	29.87%
Cagr1y	1.43%
Cagr20y	1.65%
Cagr3y	-2.94%
Cagr5y	59.77%
EPS Growth	-78.58
EPS Growth Q	-88.66
EPS Growth Years	0
EPS Growth3 Y	-36.16
EPS Growth5 Y	-11.14
FCF Growth3 Y	1.62%
FCF Growth5 Y	18.23%
OCF Growth3 Y	1.62%
OCF Growth5 Y	18.23%
Revenue Growth	-70.19x
Revenue Growth Q	-80.92x
Revenue Growth Years	0x
Revenue Growth3 Y	-30.82x
Revenue Growth5 Y	-3.77x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.17
Assets	AUD 342.9M
Cash	AUD 296.1M
Current Assets	AUD 332.2M
Current Liabilities	AUD 4.3M
Equity	AUD 338.5M
Liabilities	AUD 4.4M
Long Term Assets	AUD 10.6M
Long Term Liabilities	AUD 68,000
Net Cash	AUD 296.1M
Net Cash By Market Cap	AUD 18.29
Net Cash Growth	33.24%
Net Debt EBITDA	AUD -13.42
Net Debt Equity	AUD -0.87
Net Debt FCF	AUD -2.36
Tangible Book Value	AUD 338.5M
Tangible Book Value Per Share	AUD 2.67
WACC	12.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	76.6
Net Working Capital	AUD 31.8M
Quick ratio	74.4
Working Capital	AUD 327.9M
Working Capital Turnover	AUD 0.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	742.11%
1Y total return	1.43%
200-day SMA	16.92
3Y total return	-8.57%
50-day SMA	12.24
50-day SMA vs 200-day SMA	50under200
5Y total return	940.65%
All Time High	25.95
All Time High Change	-50.67%
All Time High Date	2023-12-28
All Time Low	0.06
All Time Low Change	21,233.33%
All Time Low Date	2009-03-05
ATR	0.52
Beta	1.56
Beta1y	0.93
Beta2y	1.39
Ch YTD	-31.22
High	13.31
High52	22.99
High52 Date	2025-10-20
High52ch	-44.31%
Low	12.58
Low52	11
Low52 Date	2026-03-23
Low52ch	16.36%
Ma50ch	4.56%
Price vs 200-day SMA	-24.35%
RSI	56.08
RSI Monthly	44.57
RSI Weekly	38.75
Sharpe ratio	0.07x
Sortino ratio	0.22
Total Return	0.01%
Tr YTD	-31.22
Tr15y	4,944.34%
Tr1m	4.07%
Tr1w	2.65%
Tr3m	2.24%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD 22M
Operating Income Growth	-88.03
Operating Income Growth Q	-93.57
Operating Income Growth3 Y	-48.04
Operating Income Growth5 Y	-16.64
Operating margin	34.09

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	109,084,491%
Shares Insiders	3.92%
Shares Institutions	22.22%
Shares Out	126,465,326
Shares Qo Q	2.76%
Shares Yo Y	-0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD 121.7M
Average Volume	290,576.95x
Bv Per Share	2.67
CAPEX	AUD -37,000
Ch10y	742.1
Ch15y	4,471.4
Ch1m	4.07
Ch1w	2.65
Ch1y	1.43
Ch20y	16.36
Ch3m	2.24
Ch3y	-8.57
Ch5y	940.7
Ch6m	-31.11
Change	-1.92%
Change From Open	0.23
Close	13.05
Days Gap	-2.15
Depreciation Amortization	23,000
Dollar Volume	6,851,558.4
Earnings Date	2026-05-29
EBIT	AUD 22M
EBITDA	AUD 22.1M
EPS	AUD 0.23
F Score	5
FCF	AUD 125.4M
FCF EV Yield	9.48x
FCF Per Share	AUD 0.99
Financing CF	-33,221,000
Fiscal Year End	December
Founded	2,001
Graham Number	3.74071
Graham Upside	-70.78
Income Tax	AUD 8.5M
Investing CF	-88,007,000
Is Primary Listing	1
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Last Split Date	2017-11-21
Last Split Type	Reverse
Lynch Fair Value	AUD 1.16
Lynch Upside	-90.91
Ma150	16.42
Ma150ch	-22.03%
Ma20	12.41
Ma20ch	3.15%
Net CF	1,074,000
Next Earnings Date	2026-05-29
Open	12.77
P FCF Ratio	12.91
P OCF Ratio	12.91
Position In Range	30.14
Ppne	45,000
Price Date	2026-05-08
Price EBITDA	AUD 73.37
Ptbv Ratio	4.78
Relative Volume	1.94x
Revenue	64,649,000x
SBC By Revenue	5.68x
Share Based Comp	3,674,000
Tax By Revenue	13.14x
Tax Rate	21.82%
Tr20y	38.68%
Tr6m	-31.11%
Volume	535,278
Z Score	271.8

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/NEU pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/NEU stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/NEU?

Insider, institutional, and short-interest positioning.

Institutional ownership

+22.2%

Share of float held by funds and institutions

Insider ownership

+3.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

ASX/NEU momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.1

Neutral momentum band

Price vs 200-day MA

-24.3%

50/200-day relationship not available

Beta (5Y)

1.56

More volatile than the market

Sharpe ratio

0.07

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/NEU

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/NEU stock rating?

asx/NEU is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/NEU analysis?

The full report lives at /stocks/asx/NEU/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/NEU?

The latest report frames asx/NEU around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/NEU page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.